Citrine Global Corp. logo

Citrine Global Corp. (CTGL)

Market Closed
10 Aug, 20:00
OTC PINK OTC PINK
$
0. 01
+0
+27.907%
$
5.37M Market Cap
- P/E Ratio
- Div Yield
75,000 Volume
0 Eps
$ 0
Previous Close
Add Transaction
Day Range
0.01 0.01
Year Range
0 0.39
Want to track CTGL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

CTGL closed yesterday higher at $0.01, an increase of 27.907% from Friday's close, completing a monthly decrease of -41.4894% or $0. Over the past 12 months, CTGL stock lost -97.1369%.
CTGL is not paying dividends to its shareholders.
The last earnings report, released on Sep 03, 2025, missed the consensus estimates by -0.0006%. On average, the company has fell short of earnings expectations by -0.0235%, based on the last three reports.
Citrine Global Corp. has completed 2 stock splits, with the recent split occurring on Oct 21, 2016.
The company's stock is traded on one exchange.

CTGL Chart

Citrine Global Corp. (CTGL) FAQ

What is the stock price today?

The current price is $0.01.

On which exchange is it traded?

Citrine Global Corp. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is CTGL.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 5.37M.

Has Citrine Global Corp. ever had a stock split?

Citrine Global Corp. had 2 splits and the recent split was on Oct 21, 2016.

Citrine Global Corp. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Ora Elharar Soffer CEO
OTC PINK Exchange
17737V105 CUSIP
US Country
18 Employees
- Last Dividend
21 Oct 2016 Last Split
- IPO Date

Overview

Citrine Global Corp. is an innovative entity based in Caesarea, Israel, focusing on the realm of plant-based wellness and pharmaceutical solutions. Originally founded in 2010 as TechCare Corp., the company underwent a significant rebranding in August 2020, emerging as Citrine Global Corp. The core mission of Citrine Global is to harness the virtues of plant-based products to enhance the quality of life for its clientele. It particularly targets the development of complementary solutions aimed at mitigating the side effects associated with conventional medication, cannabis use, other treatment methodologies, or the challenges brought on by an unbalanced lifestyle. Through its strategic operations in Israel, Citrine Global Corp. is steadfast in its commitment to advancing global wellness through innovation.

Products and Services

  • SmokLy Sprays:
  • Specifically formulated for cannabis users and tobacco smokers, SmokLy sprays are designed to offer a supportive solution for managing the challenges faced by this demographic. Citrine Global Corp. has identified a unique niche in targeting the needs of smokers, leveraging plant-based formulations to provide comfort and potential health benefits.

  • DryLess Sprays:
  • Addressing a common yet often overlooked issue, DryLess sprays cater to the adult population experiencing constant dry mouth. This includes, but is not limited to, cancer treatment patients who suffer from constant dry mouth as a side effect of their regimen. The introduction of DryLess sprays reflects Citrine Global Corp.'s commitment to enhancing the quality of life for individuals undergoing medical treatments by offering a plant-based, supportive solution to a specific, impactful problem.

Contact Information

Address: #3 Bethesda Metro Center, Suite 700
Phone: 972 9 885 1422